3B Blackbio DX Ltd Share Price Today - 3B Blackbio DX Ltd Stock Price Live NSE/BSE

3B Blackbio DX Ltd

NSE: BSE: 532067

₹1253.15

(-3.43%)

Tue, 17 Mar 2026, 03:16 am

MTF 5xInvest in 3B Blackbio DX Ltd with 5x Leverage Buy with MTF

Market Cap11.14B

PE Ratio18.73

Dividend0.31

Process Industries

Chemicals: Agricultural

24.5K

3B Blackbio DX Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1059.19
Net Profit
47.69
P/B
5.16
Sector P/E
54.62
P/E
29.05
EV/EBITDA
20.20
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
29.95
ROCE (Industry)
18.66
RONW (Industry)
16.46
ROE
19.41
ROCE
26.03
Debt/Equity
0
EPS (TTM)
66.91
Dividend Yield
0.32
Book Value
347.48
Interest Cover
582.82

Analysis

all

Pros

Dividends paid are thoroughly covered by earnings (18.3x coverage).
Kilpest India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Kilpest India is profitable, therefore cash runway is not a concern.
Kilpest India is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (112.3%, greater than 20% of total debt).

Cons

Kilpest India has only been paying a dividend for 9 years, and since then dividends per share have fallen.
Kilpest India has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
Kilpest India's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Kilpest India's dividend is below the markets top 25% of dividend payers in India (3.08%).
High level of physical assets or inventory.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	41.28	41.28	41.28	41.28	41.29
FII	2.57	2.64	0	2.49	2.68
DII	1.88	1.82	1.76	1.60	1.74
Public	54.28	54.26	56.96	54.63	54.29
Government	0	0	0	0	0

Technical Analysis

RSI

36.75

MACD

-95.19

50 DMA

1507.30

200 DMA

1456.42

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2319.42	1896.47	1623.98	1473.52	1201.03	1050.57	627.62
Fibonacci	1896.47	1734.90	1635.08	1473.52	1311.95	1212.13	1050.57
Camarilla	1467.81	1429.04	1390.27	1473.52	1312.73	1273.96	1235.19

Pivots Level: Classic

+845.90

2319.42

+422.95

1896.47

+150.47

1623.98

1473.52

Pivot Point

LTP: 1234.10

-272.48

1201.03

-422.95

1050.57

-845.90

627.62

Moving Average

SMAEMA

Period

Value

10-EMA
1273.08
20-EMA
1355.40
30-EMA
1402.17
50-EMA
1436.44
100-EMA
1450.73
200-EMA
1470.22

Announcement Date	Purpose	Action	Ex Date
06 Feb 2026	board-meetings	Quarterly Results
13 Nov 2025	board-meetings	Quarterly Results
04 Sept 2025	agm
19 Aug 2025	dividend	Dividend - Rs. - 4	19 Sept 2025
28 May 2025	dividend	₹4.00 Dividend /Share	19 Sept 2025
04 Sept 2024	agm
29 May 2024	dividend	₹3.00 Dividend /Share	18 Sept 2024
26 Aug 2023	agm
29 May 2023	dividend	₹2.50 Dividend /Share	15 Sept 2023
29 Sept 2022	egm

3B Blackbio DX Ltd

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Apollo Hospitals Enterprise Ltd

Fortis Healthcare Ltd

3B Blackbio DX Ltd About

3D Blackbio DX is a leading Indian Biotechnology Company specializing in the Design, Development, Manufacturing, and Commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance. The company provides a comprehensive portfolio of qPCR-based assays, Rapid Tests and NGS-based molecular diagnostic kits for accurate and reliable testing on patient samples.

Industry

Healthcare

Founded

1972

Headquarters

CEO

D K Dubey

Employees

Contact

Website

http://www.kilpest.com

dkdkilpest@yahoo.co.in

Phone

91-0755-2586536/2586537

Location

7-C Industrial Area, Govindpura, Bhopal, Madhya Pradesh, 462023

Year	History
2011	Kilpest India Ltd launched a Novel Biotech Indo-Spain JV project at Bhopal M.P. The company received an order for Rs. 7 Millions for supply of pesticide to be used in mosquito control program, from Dept. of Health & Family Welfare, Govt. of Orissa The company launched Diagnostic Services
2012	Kilpest India Ltd received orders worth Rs. 13.00 millions for supply of pesticides to be used in mosquito control programme, from Department of Health & Family Welfare, Govt. of Odisha. The company received orders worth Rs. 12.00 millions for supply of pesticides to be used in mosquito control programme, from Directorate of Health Services, Govt. of Madhya Pradesh. The company bagged an order worth Rs 6.71 million from Municipal Corporation of Delhi for supplying pesticides to be used in mosquito control programme.
2017	Kilpest India arm bagged an award from FMPCCI, Bhopal.
2018	Kilpest India arm bagged the MSME National Award 2018.
2023	The company name was changed to 3B BlackBio Dx Ltd. from Kilpest India Ltd.

Client Name	Order Side	QTY	Avg Price	Date
NIRANJAN S SHETY	Sell	105000	287.44	26 Feb 2021
YUGA DOSHI	Buy	45000	319.17	14 Sept 2020
ALPHA LEON ENTERPRISES LLP	Buy	41020	481.41	10 Aug 2020
ALPHA LEON ENTERPRISES LLP	Sell	56496	491.64	10 Aug 2020
LENUS FINVEST PRIVATE LIMITED	Buy	40000	492.89	10 Aug 2020
SEVEN CANYONS WORLD INNOVATORS FUND	Buy	170000	360	29 Jul 2020
OWN INFRACON PRIVATE LIMITED	Sell	100000	360	29 Jul 2020
VARUN DAGA	Sell	100000	360	29 Jul 2020
ALPHA LEON ENTERPRISES LLP	Sell	61497	276.85	16 Jul 2020
ALPHA LEON ENTERPRISES LLP	Buy	38469	276.41	16 Jul 2020

3B Blackbio DX Ltd News

3B BlackBio Dx schedules analyst meet with Fair Value

3B BlackBio Dx Ltd. announces virtual one-on-one analyst meeting with Fair Value Capital scheduled for March 17, 2026 at 4:00 PM under SEBI Regulation 30 compliance.

12 Mar 2026

stocks

3B BlackBio Dx CEO Updates on MEDLAB Dubai Success

3B BlackBio Dx Limited's CEO reports successful participation at MEDLAB Dubai from February 9-14, 2026, highlighting global brand recognition for TRUPCR and identifying potential M&A targets while rescheduling shareholder call to February 21st.

19 Feb 2026

stocks

3B BlackBio Dx Reports Strong Q3FY26 Performance

3B BlackBio Dx Limited delivered robust Q3FY26 results with consolidated revenue of ₹5034.73 lakhs and net profit of ₹2244.29 lakhs, driven by strong diagnostic kits segment performance.

06 Feb 2026

co actions results

3B BlackBio Dx Board Meeting Set for Feb 6, 2026

3B BlackBio Dx Limited has scheduled a board meeting on February 6, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window closed from January 1, 2026.

30 Jan 2026

co actions results

3B BlackBio DX Share Sale by Promoter Disclosed

Mahesh Kumar Upadhyay sold 400 equity shares of 3B BlackBio DX Limited through open market transactions on December 23-24, 2025, reducing his holding from 24,250 to 23,850 shares.

24 Dec 2025

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800